(Q73668726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

meta-analysis

0 references

title

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

main subject

phase I clinical trial

1 reference

2

I Ray-Coquard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

T Bachelot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Catimel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Ardiet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J P Guastalla

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Dumortier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Chauvin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J P Droz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

T Philip

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Clavel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

151-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

Critical role of phase I clinical trials in cancer treatment. American Society of Clinical Oncology

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

A phase I trial on the ethics of phase I trials.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

How long have I got doctor?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Predicting life span for applicants to inpatient hospice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Responses and toxic deaths in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Prognostic factors for survival in patients treated in phase I clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Race, nutritional status, and survival from breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008368319526

7 January 2021

Identifiers

DOI

10.1023/A:1008368319526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10761748%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference